Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy
General Benefits
Ozempic, Wegovy and Mounjaro are all administered on a weekly basis through a subcutaneous injection, with the outlier being Mounjaro due to the significantly higher starting dosage (2.5mg compared to 0.5mg for the other two)
In the case that one has at least one medical condition resulting from obesity, like hypertension, diabetes, sleep apnea, etc., this drug could be used starting at a BMI of 27, which would be equivalent to a lower weight compared to healthier individuals
10.1172/JCI97233 Summary Keywords obsessive-compulsive disorder, autism, glucagon-like peptide-1 agonist, intellectual disability, weight, overeating Citation Jrvinen A, Laine MK, Tikkanen R and Castrn ML (2019) Beneficial Effects of GLP-1 Agonist in a Male With Compulsive Food-Related Behavior Associated With Autism
Are There Hidden Fees I Should Watch For